Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Selling Bioline RX Ltd (BLRX)

We view hedge fund activity in the stock unfavorable, but, in this case, there was only a single hedge fund selling its entire position: Broadfin Capital. One hedge fund selling its entire position doesn’t always imply a bearish intent. Theoretically a hedge fund may decide to sell a promising position in order to invest the proceeds in a more promising idea. However, we don’t think this is the case in this case because none of the 700+ hedge funds tracked by Insider Monkey identified BLRX as a viable investment and initiated a position in the stock.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Bioline RX Ltd (NASDAQ:BLRX) but similarly valued. We will take a look at Intec Pharma Ltd (NASDAQ:NTEC), Harvest Natural Resources, Inc. (NYSE:HNR), TheStreet, Inc. (NASDAQ:TST), and GigOptix Inc (NYSEMKT:GIG). This group of stocks’ market values resemble BLRX’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
NTEC 5 14162 5
HNR 7 5239 -3
TST 7 15625 0
GIG 7 8561 2

As you can see these stocks had an average of 6.5 hedge funds with bullish positions and the average amount invested in these stocks was $11 million. That figure was $10 million in BLRX’s case. Harvest Natural Resources, Inc. (NYSE:HNR) is the most popular stock in this table. On the other hand, Intec Pharma Ltd (NASDAQ:NTEC) is the least popular one with only 5 bullish hedge fund positions. Bioline RX Ltd (NASDAQ:BLRX) is not the least popular stock in this group, but hedge fund interest is still not impressive enough to spend our time analyzing it. Based on our extensive studies, we consider that the best approach is to focus on analyzing stocks that hedge funds are collectively the fondest of and, in this case, HNR might be a better candidate to consider a long position.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...